109 related articles for article (PubMed ID: 70147)
1. [Changes of antithrombin (antithrombin III, alpha2-macroglobulin) in various diseases (author's transl)].
Matsuda T; Ogawara M; Kodama N; Murakami M
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):261-6. PubMed ID: 70147
[No Abstract] [Full Text] [Related]
2. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
Matsuda T
Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
[No Abstract] [Full Text] [Related]
3. Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels.
Walker ID; Davidson JF; Young P; Conkie JA
Thromb Diath Haemorrh; 1975 Sep; 34(1):106-14. PubMed ID: 52896
[TBL] [Abstract][Full Text] [Related]
4. [Effects of alpha2-macroglobulin and FDP on the antithrombin III assay system (author's transl)].
Yoshida N; Tachiya K; Moroi M; Matsuda M; Aoki N
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):197-201. PubMed ID: 70144
[No Abstract] [Full Text] [Related]
5. Human alpha2-macroglobulin and its antitrypsic and antithrombin activities in serum and plasma.
de Vonne TL; Mouray H
Clin Chim Acta; 1978 Nov; 90(1):83-5. PubMed ID: 82495
[TBL] [Abstract][Full Text] [Related]
6. [Significance of the inhibitors in disseminated intravascular coagulation syndrome and relationship among antithrombin III, platelet factor 4 and heparin (author's transl)].
Sakuragawa N; Takahashi K; Hoshiyama M; Matsuoka M
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):218-26. PubMed ID: 578067
[No Abstract] [Full Text] [Related]
7. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
[TBL] [Abstract][Full Text] [Related]
8. [Study of antithrombin III in pancreatitis (author's transl)].
Uehara S; Hirayama A
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):248-54. PubMed ID: 70146
[No Abstract] [Full Text] [Related]
9. Immunologic measurement of antithrombin III-heparin cofactor and alpha2 macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy.
Damus PS; Wallace GA
Thromb Res; 1975 Jan; 6(1):27-38. PubMed ID: 46627
[No Abstract] [Full Text] [Related]
10. [Consumption of antithrombin III in plasma (author's transl)].
Matsuda T
Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):597-603. PubMed ID: 696198
[No Abstract] [Full Text] [Related]
11. Effects of alpha 2-macroglobulin on DIC.
Igarashi M; Takatsuka J; Asada T
Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1118-22. PubMed ID: 87100
[No Abstract] [Full Text] [Related]
12. [Immunological assay of antithrombin (anthrombin III and alpha2-macroglobulin) (author's transl)].
Meguro T; Yamada K; Shirahata A
Rinsho Byori; 1975 Aug; 23(8):635-8. PubMed ID: 811830
[No Abstract] [Full Text] [Related]
13. [Comparison between anticoagulant activity and antigenicity of plasma antithrombin III in healthy subjects and patients with disseminated intravascular coagulation (DIC) (author's transl)].
Matsuda T; Ogawara M; Miura R; Seki T; Yokouchi M; Murakami M; Fujisawa M; Nakanishi K; Nakamura S
Rinsho Ketsueki; 1980 Mar; 21(3):341-6. PubMed ID: 6157843
[No Abstract] [Full Text] [Related]
14. Measurement of antithrombin III, alpha 2-macroglobulin and alpha 1-antitrypsin in patients with deep venous thrombosis and pulmonary embolism.
de Boer AC; van Riel LA; den Ottolander GJ
Thromb Res; 1979; 15(1-2):17-25. PubMed ID: 90398
[No Abstract] [Full Text] [Related]
15. [Antithrombin II. Immunological and biological levels in hepatic cirrhosis and in disseminated intravascular coagulation (author's transl)].
Barrantes A; Fonseca JE
Sangre (Barc); 1979; 24(6):1043-7. PubMed ID: 538557
[No Abstract] [Full Text] [Related]
16. [Haemostatic changes related to extracorporeal circulation (ECC) (author's transl)].
Witzke G; Elert O
Anaesthesist; 1981 Feb; 30(2):64-70. PubMed ID: 6164310
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin III activity and other coagulation changes in proliferative diabetic retinopathy.
Elder GE; Mayne EE; Daly JG; Kennedy AL; Hadden DR; Montgomery DA; Weaver JA
Haemostasis; 1980; 9(5):288-96. PubMed ID: 6157610
[TBL] [Abstract][Full Text] [Related]
18. [Hypercoagulability and stroke (author's transl)].
Matsuda T
No To Shinkei; 1978 Jan; 30(1):13-25. PubMed ID: 346028
[No Abstract] [Full Text] [Related]
19. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
[No Abstract] [Full Text] [Related]
20. [Antithrombin III deficiency and tendency to thrombosis (author's transl)].
Lechner K; Thaler E; Niessner H; Nowotny C; Partsch H
Wien Klin Wochenschr; 1977 Apr; 89(7):215-22. PubMed ID: 857429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
